plerixafor

Poland

Drugs containing this active substance

  • PLERIXAFOR BIOFAR

    The medicine is used to facilitate the collection of hematopoietic stem cells for subsequent storage and transplantation. It is intended for adults with lymphoma or multiple myeloma and for children (from 1 to 18 years of age) with lymphoma or solid tumors.

    Form: solution for injection

    Active substance Dosage
    plerixafor 20 mg/ml

    ATC: L03AX16

    Manufacturer: Seacross Pharma (Europe) Limited

  • PLERIXAFOR MSN

    The medicine is used to facilitate the collection of hematopoietic stem cells for subsequent storage and transplantation. It is intended for adults with lymphoma or multiple myeloma and for children (from 1 to 18 years of age) with lymphoma or solid tumors.

    Form: solution for injection

    Active substance Dosage
    plerixafor 20 mg/ml

    ATC: L03AX16

    Manufacturer: MSN Labs Europe Limited Pharmadox Healthcare Ltd.

  • PLERIXAFOR ZENTIVA

    The medicine is used to facilitate the collection of hematopoietic stem cells for later storage and transplantation. It is intended for adults with lymphoma or multiple myeloma and for children (from 1 to 18 years of age) with lymphoma or solid tumors.

    Form: solution for injection

    Active substance Dosage
    plerixafor 20 mg/ml

    ATC: L03AX16

    Manufacturer: Pharmadox Healthcare Ltd.